Tscan Therapeutics Inc’s (NASDAQ: TCRX) 2.61% Incline Frightens Investors Off The Stock
Tscan Therapeutics Inc (NASDAQ:TCRX) traded at $1.57 at close of the session on Tuesday, April 22 and made an upward move of 2.61% on its previous day’s price. Looking at the stock we see that its previous close was $1.53 and the beta (5Y monthly)